Calcineurin inhibitors are a class of medications that are commonly used in dermatology for the treatment of inflammatory skin conditions such as atopic dermatitis and psoriasis. These agents inhibit the activity of calcineurin, a protein phosphatase that is involved in T-cell activation and cytokine production

There are two main calcineurin inhibitors used in dermatology: tacrolimus and pimecrolimus. These medications are available in topical formulations and are applied directly to the affected skin. They are particularly useful in areas where corticosteroids may not be appropriate or effective, such as the face and skin folds.

In this learning module, you will find a comprehensive review of calcineurin inhibitors, including their mechanism of action, indications, contraindications, adverse effects, and drug interactions.

To test your knowledge, we invite you to complete the associated quiz.

Select how you would like to proceed below:

1. Bolognia J, Schaffer JV, Cerroni L. Dermatology. 4th edition ed: Philadelphia, Pa.: Elsevier; 2018 9th November 2017. 2880 p.

2. Wolverton SE, Wu JJ. Comprehensive dermatologic drug therapy. 4th edition ed: Philadelphia, PA: Elsevier; 2021 19th March 2020. 1024 p.